Bazedoxifene/conjugated estrogens in combination with leuprolide for the treatment of endometriosis

Key Clinical Message Bazedoxifene/conjugated estrogens can be used with leuprolide as effective add‐back therapy in premenopausal women with endometriosis without unwanted stimulation of the breasts, CNS (Central Nervous System), or endometrium. Bazedoxifene/conjugated estrogens may be an effective...

Full description

Saved in:
Bibliographic Details
Published inClinical case reports Vol. 6; no. 6; pp. 990 - 994
Main Authors Hill, Amanda M., Lessey, Bruce, Flores, Valerie A., Taylor, Hugh S.
Format Journal Article
LanguageEnglish
Published England John Wiley & Sons, Inc 01.06.2018
John Wiley and Sons Inc
Subjects
Bazedoxifene
Case Report
Case Reports
Endocrine therapy
Endometriosis
Estrogens
pelvic pain
SERMs
endometriosis
pelvic pain
SERMs
Bazedoxifene
Online AccessGet full text

Cover

More Information
Summary:Key Clinical Message Bazedoxifene/conjugated estrogens can be used with leuprolide as effective add‐back therapy in premenopausal women with endometriosis without unwanted stimulation of the breasts, CNS (Central Nervous System), or endometrium. Bazedoxifene/conjugated estrogens may be an effective progestin‐free alternative to traditional add‐back therapies. Bazedoxifene/conjugated estrogens can be used with leuprolide as effective add‐back therapy in premenopausal women with endometriosis without unwanted stimulation of the breasts, CNS, or endometrium. Bazedoxifene/conjugated estrogens may be an effective progestin‐free alternative to traditional add‐back therapies.
ISSN:2050-0904
2050-0904
DOI:10.1002/ccr3.1501